Replies to post #8799 on Pluristem Therapeutics Inc (PSTI)

[Spideyboy]

Oi veh!

Of course current and past cash burn does not reflect upcoming clinical costs.

If you read my sentences, I was referring to the fact that a specific quarterly cash burn needs to be looked at in relevance to the period of time to which they did or did not have access to grant funding.

In further explanation for you. If the 5.1 million burn was over a period of time when they did not have access to grant funding, or has less grant funding, then now that they do have the grant funds, would this not mean that going forward their quarterly cash burn, being supported by the grants, could/would be less.

And yes I don't think the grants will cover all of the cost of each trial, but will go a good way nonetheless.

Would you please read things calmly, objectively and in full before lashing out. It does appear your emotions are getting the better of you.

Now Scott, to whom I was replying, as someone that has put in time to look at these financials, I'd be very happy to hear your thoughts on my post to you and making a constructive discussion to get a clearer picture to all of this.